Reduced Autophagy in 5-Fluorouracil Resistant Colon Cancer Cells

We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level...

Full description

Saved in:
Bibliographic Details
Published inBiomolecules & therapeutics Vol. 25; no. 3; pp. 315 - 320
Main Authors Yao, Cheng Wen, Kang, Kyoung Ah, Piao, Mei Jing, Ryu, Yea Seong, Fernando, Pattage Madushan Dilhara Jayatissa, Oh, Min Chang, Park, Jeong Eon, Shilnikova, Kristina, Jeong, Seung Uk, Boo, Sun-Jin, Hyun, Jin Won
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Applied Pharmacology 01.05.2017
한국응용약물학회
Subjects
Online AccessGet full text
ISSN2005-4483
1976-9148
1976-9148
2005-4483
DOI10.4062/biomolther.2016.069

Cover

Abstract We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level of GFP-LC3 puncta. In addition, expression of critical autophagic proteins such as Atg5, Beclin-1 and LC3-II and autophagic flux was diminished in SNUC5/5-FUR cells. Whereas production of reactive oxygen species (ROS) was significantly elevated in SNUC5/5-FUR cells, treatment with the ROS inhibitor N-acetyl cysteine further reduced the level of autophagy. Taken together, these results indicate that decreased autophagy is linked to 5-FU resistance in SNUC5 colon cancer cells.
AbstractList We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5-FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level of GFP-LC3 puncta. In addition, expression of critical autophagic proteins such as Atg5, Beclin-1 and LC3-II and autophagic flux was diminished in SNUC5/5-FUR cells. Whereas production of reactive oxygen species (ROS) was significantly elevated in SNUC5/5-FUR cells, treatment with the ROS inhibitor N-acetyl cysteine further reduced the level of autophagy. Taken together, these results indicate that decreased autophagy is linked to 5-FU resistance in SNUC5 colon cancer cells.
We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level of GFP-LC3 puncta. In addition, expression of critical autophagic proteins such as Atg5, Beclin-1 and LC3-II and autophagic flux was diminished in SNUC5/5-FUR cells. Whereas production of reactive oxygen species (ROS) was significantly elevated in SNUC5/5-FUR cells, treatment with the ROS inhibitor N-acetyl cysteine further reduced the level of autophagy. Taken together, these results indicate that decreased autophagy is linked to 5-FU resistance in SNUC5 colon cancer cells. KCI Citation Count: 26
We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level of GFP-LC3 puncta. In addition, expression of critical autophagic proteins such as Atg5, Beclin-1 and LC3-II and autophagic flux was diminished in SNUC5/5-FUR cells. Whereas production of reactive oxygen species (ROS) was significantly elevated in SNUC5/5-FUR cells, treatment with the ROS inhibitor N-acetyl cysteine further reduced the level of autophagy. Taken together, these results indicate that decreased autophagy is linked to 5-FU resistance in SNUC5 colon cancer cells.We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of autophagy, as determined by light microscopy, confocal microscopy, and flow cytometry following acridine orange staining, and the decreased level of GFP-LC3 puncta. In addition, expression of critical autophagic proteins such as Atg5, Beclin-1 and LC3-II and autophagic flux was diminished in SNUC5/5-FUR cells. Whereas production of reactive oxygen species (ROS) was significantly elevated in SNUC5/5-FUR cells, treatment with the ROS inhibitor N-acetyl cysteine further reduced the level of autophagy. Taken together, these results indicate that decreased autophagy is linked to 5-FU resistance in SNUC5 colon cancer cells.
Author Kang, Kyoung Ah
Park, Jeong Eon
Hyun, Jin Won
Yao, Cheng Wen
Shilnikova, Kristina
Piao, Mei Jing
Jeong, Seung Uk
Ryu, Yea Seong
Oh, Min Chang
Fernando, Pattage Madushan Dilhara Jayatissa
Boo, Sun-Jin
AuthorAffiliation 2 School of Medicine No.2, Jeju National University, Jeju 63241, Republic of Korea
1 School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
AuthorAffiliation_xml – name: 1 School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– name: 2 School of Medicine No.2, Jeju National University, Jeju 63241, Republic of Korea
Author_xml – sequence: 1
  givenname: Cheng Wen
  surname: Yao
  fullname: Yao, Cheng Wen
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 2
  givenname: Kyoung Ah
  surname: Kang
  fullname: Kang, Kyoung Ah
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 3
  givenname: Mei Jing
  surname: Piao
  fullname: Piao, Mei Jing
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 4
  givenname: Yea Seong
  surname: Ryu
  fullname: Ryu, Yea Seong
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 5
  givenname: Pattage Madushan Dilhara Jayatissa
  surname: Fernando
  fullname: Fernando, Pattage Madushan Dilhara Jayatissa
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 6
  givenname: Min Chang
  surname: Oh
  fullname: Oh, Min Chang
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 7
  givenname: Jeong Eon
  surname: Park
  fullname: Park, Jeong Eon
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 8
  givenname: Kristina
  surname: Shilnikova
  fullname: Shilnikova, Kristina
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
– sequence: 10
  givenname: Seung Uk
  surname: Jeong
  fullname: Jeong, Seung Uk
  organization: School of Medicine No.2, Jeju National University, Jeju 63241, Republic of Korea
– sequence: 11
  givenname: Sun-Jin
  surname: Boo
  fullname: Boo, Sun-Jin
  organization: School of Medicine No.2, Jeju National University, Jeju 63241, Republic of Korea
– sequence: 12
  givenname: Jin Won
  surname: Hyun
  fullname: Hyun, Jin Won
  organization: School of Medicine No.1 and Institute for Nuclear Science and Technology, Jeju National University, Jeju 63243, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27737524$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002220510$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqNkc1O3DAUhS0EgoH2CZBQlu0iU__FSTZVR1FpkZCQRrO3HOeGMXjswXao5u2bdKBAN2V1Fz7nfL7nnqJD5x0gdE7wnGNBv7TGb7xNawhziomYY1EfoBmpS5HXhFeHaEYxLnLOK3aCTmO8w1iUpBDH6ISWJSsLymfo2xK6QUOXLYbkt2t1u8uMy4r80g4--CEobWy2hGhiUi5ljbfeZY1yGkLWgLXxAzrqlY3w8WmeodXl91XzM7---XHVLK5zzVmdckV1xzrVCz7-XYtW10wLVvXAiSo5BsqwLhgt-w5aAZqVVdtTylnXkkIrzc7Q532sC72810Z6Zf7MWy_vg1wsV1eSMCEwqUct32sHt1W7X8pauQ1mo8JOEiyn7uRLd3LqTo7djbave9t2aDfQaXApqBfrBHz74sx6xD_KglMuOB0DPj0FBP8wQExyY6IeS1IO_BAlqVjBCRH1JL14zfoLeT7MKKj3Ah18jAF6qU1SyfgJbex_FmH_eN-z_m-8i7l_
CitedBy_id crossref_primary_10_4062_biomolther_2020_003
crossref_primary_10_3892_mmr_2018_8661
crossref_primary_10_1016_j_ejphar_2022_175253
crossref_primary_10_3390_biomedicines10112690
crossref_primary_10_1002_jcp_26356
crossref_primary_10_3390_ijms22179286
crossref_primary_10_4062_biomolther_2022_028
crossref_primary_10_1016_j_biocel_2020_105732
crossref_primary_10_3390_antiox8100471
crossref_primary_10_3892_ijo_2017_4182
crossref_primary_10_1016_j_ecoenv_2023_115061
crossref_primary_10_1096_fba_2022_00099
crossref_primary_10_4062_biomolther_2019_107
crossref_primary_10_3390_biology10090854
crossref_primary_10_3390_cells8111349
crossref_primary_10_1016_j_bioorg_2025_108343
crossref_primary_10_1016_S1875_5364_20_30012_1
crossref_primary_10_3389_fphar_2021_729367
crossref_primary_10_2174_1871520621666210608104021
crossref_primary_10_1016_j_ijpharm_2021_120973
crossref_primary_10_1186_s13046_017_0661_7
crossref_primary_10_1016_j_lfs_2022_120699
crossref_primary_10_1039_c7pp00014f
crossref_primary_10_1172_jci_insight_138835
crossref_primary_10_1016_j_lfs_2020_118745
crossref_primary_10_1634_theoncologist_2019_0874
crossref_primary_10_3390_biomedicines11010197
crossref_primary_10_1016_j_fct_2021_112696
crossref_primary_10_1007_s00005_021_00629_2
crossref_primary_10_3390_nu14173558
Cites_doi 10.1038/cddis.2014.149
10.1101/gad.1565707
10.1186/1471-2407-10-370
10.1093/emboj/19.21.5720
10.1074/jbc.M602097200
10.1002/path.2697
10.1038/cddis.2013.273
10.4143/crt.2005.37.1.1
10.1242/jcs.093708
10.1245/s10434-008-0260-0
10.1097/CAD.0b013e328353f8c7
10.1101/gad.2016211
10.1038/nrc1074
10.1038/sj.cdd.4401765
10.1042/BJ20111451
10.4161/auto.6.7.12113
10.5483/BMBRep.2016.49.2.265
10.1023/A:1006416410198
10.1101/gad.1545107
10.5487/TR.2015.31.2.151
10.1111/j.1445-2197.2006.03726.x
10.1016/j.phymed.2015.06.008
10.1111/j.1742-7843.2007.00115.x
10.1038/nrm3249
10.1002/ijc.24943
10.4174/jkss.2011.81.2.115
10.1016/j.bmc.2005.12.035
10.1007/s10529-009-0039-9
10.1089/ars.2010.3478
10.1038/sj.onc.1207521
ContentType Journal Article
Copyright Copyright ©2017, The Korean Society of Applied Pharmacology 2017
Copyright_xml – notice: Copyright ©2017, The Korean Society of Applied Pharmacology 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.4062/biomolther.2016.069
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
EISSN 1976-9148
2005-4483
EndPage 320
ExternalDocumentID oai_kci_go_kr_ARTI_1366019
oai:pubmedcentral.nih.gov:5424642
PMC5424642
27737524
10_4062_biomolther_2016_069
Genre Journal Article
GroupedDBID ---
23N
5-W
5GY
8JR
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
DU5
EF.
F5P
HYE
HZB
JDI
KQ8
M48
OK1
PGMZT
RPM
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
ID FETCH-LOGICAL-c439t-a2cd3daf64406c6bc93c638fe41a740e230c5327fdeb6ec378bf2243db15cac3
IEDL.DBID UNPAY
ISSN 2005-4483
1976-9148
IngestDate Sun Mar 09 07:53:29 EDT 2025
Wed Oct 29 12:06:50 EDT 2025
Thu Aug 21 18:20:15 EDT 2025
Fri Jul 11 15:33:32 EDT 2025
Mon Jul 21 05:57:21 EDT 2025
Tue Jul 01 04:15:27 EDT 2025
Thu Apr 24 23:09:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Keywords Reactive oxygen species
Colon cancer
5-Fluorouracil
SNUC5/5-FUR
Autophagy
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-a2cd3daf64406c6bc93c638fe41a740e230c5327fdeb6ec378bf2243db15cac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000363.2017.25.3.006
OpenAccessLink https://proxy.k.utb.cz/login?url=http://doi.org/10.4062/biomolther.2016.069
PMID 27737524
PQID 1835411692
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1366019
unpaywall_primary_10_4062_biomolther_2016_069
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5424642
proquest_miscellaneous_1835411692
pubmed_primary_27737524
crossref_citationtrail_10_4062_biomolther_2016_069
crossref_primary_10_4062_biomolther_2016_069
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Biomolecules & therapeutics
PublicationTitleAlternate Biomol Ther (Seoul)
PublicationYear 2017
Publisher The Korean Society of Applied Pharmacology
한국응용약물학회
Publisher_xml – name: The Korean Society of Applied Pharmacology
– name: 한국응용약물학회
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
22066110 - J Korean Surg Soc. 2011 Aug;81(2):115-21
26191381 - Toxicol Res. 2015 Jun;31(2):151-6
17606641 - Genes Dev. 2007 Jul 1;21(13):1621-35
17510285 - Genes Dev. 2007 Jun 1;21(11):1367-81
11060023 - EMBO J. 2000 Nov 1;19(21):5720-8
16413786 - Bioorg Med Chem. 2006 May 1;14(9):3218-22
22166994 - Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12
22187934 - Biochem J. 2012 Jan 15;441(2):523-40
16768699 - ANZ J Surg. 2006 May;76(5):373-80
19956504 - Cancer Res Treat. 2005 Feb;37(1):1-19
20225336 - J Pathol. 2010 May;221(1):3-12
22561420 - Anticancer Drugs. 2012 Aug;23(7):675-82
12724731 - Nat Rev Cancer. 2003 May;3(5):330-8
16247502 - Cell Death Differ. 2005 Nov;12 Suppl 2:1542-52
26321739 - Phytomedicine. 2015 Sep 15;22(10):902-10
16857678 - J Biol Chem. 2006 Oct 13;281(41):30373-82
19495564 - Biotechnol Lett. 2009 Oct;31(10):1485-92
19116755 - Ann Surg Oncol. 2009 Mar;16(3):761-71
20505317 - Autophagy. 2010 Oct;6(7):838-54
20712403 - Antioxid Redox Signal. 2011 Jun;14(11):2251-69
26698872 - BMB Rep. 2016 Feb;49(2):73-80
21498569 - Genes Dev. 2011 Apr 15;25(8):795-800
11081567 - Invest New Drugs. 2000 Nov;18(4):299-313
3802100 - Cancer Res. 1987 Feb 15;47(4):936-42
15077152 - Oncogene. 2004 Apr 12;23(16):2891-906
22641689 - J Cell Sci. 2012 May 15;125(Pt 10):2349-58
17845510 - Basic Clin Pharmacol Toxicol. 2007 Oct;101(4):277-85
24743738 - Cell Death Dis. 2014 Apr 17;5:e1183
19816940 - Int J Cancer. 2010 May 15;126(10):2457-68
23907464 - Cell Death Dis. 2013 Aug 01;4:e750
20630104 - BMC Cancer. 2010 Jul 15;10:370
References_xml – ident: ref15
  doi: 10.1038/cddis.2014.149
– ident: ref14
  doi: 10.1101/gad.1565707
– ident: ref28
  doi: 10.1186/1471-2407-10-370
– ident: ref13
  doi: 10.1093/emboj/19.21.5720
– ident: ref6
  doi: 10.1074/jbc.M602097200
– ident: ref8
  doi: 10.1002/path.2697
– ident: ref16
  doi: 10.1038/cddis.2013.273
– ident: ref19
  doi: 10.4143/crt.2005.37.1.1
– ident: ref22
  doi: 10.1242/jcs.093708
– ident: ref21
  doi: 10.1245/s10434-008-0260-0
– ident: ref27
  doi: 10.1097/CAD.0b013e328353f8c7
– ident: ref29
  doi: 10.1101/gad.2016211
– ident: ref23
  doi: 10.1038/nrc1074
– ident: ref31
  doi: 10.1038/sj.cdd.4401765
– ident: ref11
  doi: 10.1042/BJ20111451
– ident: ref5
  doi: 10.4161/auto.6.7.12113
– ident: ref18
  doi: 10.5483/BMBRep.2016.49.2.265
– ident: ref10
  doi: 10.1023/A:1006416410198
– ident: ref24
  doi: 10.1101/gad.1545107
– ident: ref2
– ident: ref17
  doi: 10.5487/TR.2015.31.2.151
– ident: ref26
  doi: 10.1111/j.1445-2197.2006.03726.x
– ident: ref30
  doi: 10.1016/j.phymed.2015.06.008
– ident: ref12
  doi: 10.1111/j.1742-7843.2007.00115.x
– ident: ref4
  doi: 10.1038/nrm3249
– ident: ref1
  doi: 10.1002/ijc.24943
– ident: ref3
  doi: 10.4174/jkss.2011.81.2.115
– ident: ref7
  doi: 10.1016/j.bmc.2005.12.035
– ident: ref20
  doi: 10.1007/s10529-009-0039-9
– ident: ref25
  doi: 10.1089/ars.2010.3478
– ident: ref9
  doi: 10.1038/sj.onc.1207521
– reference: 26698872 - BMB Rep. 2016 Feb;49(2):73-80
– reference: 19495564 - Biotechnol Lett. 2009 Oct;31(10):1485-92
– reference: 22561420 - Anticancer Drugs. 2012 Aug;23(7):675-82
– reference: 24743738 - Cell Death Dis. 2014 Apr 17;5:e1183
– reference: 22187934 - Biochem J. 2012 Jan 15;441(2):523-40
– reference: 19816940 - Int J Cancer. 2010 May 15;126(10):2457-68
– reference: 17510285 - Genes Dev. 2007 Jun 1;21(11):1367-81
– reference: 16857678 - J Biol Chem. 2006 Oct 13;281(41):30373-82
– reference: 16413786 - Bioorg Med Chem. 2006 May 1;14(9):3218-22
– reference: 22066110 - J Korean Surg Soc. 2011 Aug;81(2):115-21
– reference: 11081567 - Invest New Drugs. 2000 Nov;18(4):299-313
– reference: 21498569 - Genes Dev. 2011 Apr 15;25(8):795-800
– reference: 20225336 - J Pathol. 2010 May;221(1):3-12
– reference: 11060023 - EMBO J. 2000 Nov 1;19(21):5720-8
– reference: 15077152 - Oncogene. 2004 Apr 12;23(16):2891-906
– reference: 20712403 - Antioxid Redox Signal. 2011 Jun;14(11):2251-69
– reference: 26321739 - Phytomedicine. 2015 Sep 15;22(10):902-10
– reference: 19956504 - Cancer Res Treat. 2005 Feb;37(1):1-19
– reference: 20505317 - Autophagy. 2010 Oct;6(7):838-54
– reference: 22641689 - J Cell Sci. 2012 May 15;125(Pt 10):2349-58
– reference: 23907464 - Cell Death Dis. 2013 Aug 01;4:e750
– reference: 3802100 - Cancer Res. 1987 Feb 15;47(4):936-42
– reference: 20630104 - BMC Cancer. 2010 Jul 15;10:370
– reference: 17606641 - Genes Dev. 2007 Jul 1;21(13):1621-35
– reference: 19116755 - Ann Surg Oncol. 2009 Mar;16(3):761-71
– reference: 22166994 - Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12
– reference: 26191381 - Toxicol Res. 2015 Jun;31(2):151-6
– reference: 16247502 - Cell Death Differ. 2005 Nov;12 Suppl 2:1542-52
– reference: 16768699 - ANZ J Surg. 2006 May;76(5):373-80
– reference: 12724731 - Nat Rev Cancer. 2003 May;3(5):330-8
– reference: 17845510 - Basic Clin Pharmacol Toxicol. 2007 Oct;101(4):277-85
SSID ssj0067156
Score 2.2424996
Snippet We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5- FUR cells exhibited low level of...
We investigated the role of autophagy in SNUC5/5-FUR, 5-fluorouracil (5-FU) resistant SNUC5 colon cancer cells. SNUC5/5-FUR cells exhibited low level of...
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 315
SubjectTerms Original
약학
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbacoALAvEKLxnEkSzxI3ZygmrFqiCVQ9VKvVmOH2VVy2mzG8H-e8bZ3cCKgnrKIXYsz-fJfBM73yD0TruKeWdcLgrGc17TJq-scDkn1hmmrffDRvvxN3F0xr-el-d7aFsVdWPAxY2pXaonddaFyc_r1UdweOCvEwhH9EP6Ub0NiS-lo1piUoh6H92BUFWnWg7HfNxWEJIM5VwJxGDwcl6tZYj-9ZCdULUfO38TC_37MOXdPl7p1Q8dwh-RavYA3d9QTHy4XhMP0Z6Lj9Cnk6TR6iw-7JOUgL5Y4XnEZT4LfdtBD23mAZ-4RaKTcYmn8E6MeJqWRIenLoTFY3Q6-3w6Pco31RNyAyRjmWtqLLPaA-EphBGNqZkBZ_OOEy154SD3MCWj0lvXCMBFVo2HeM5sQ0qjDXuCDmIb3TOEtSi98CV3lWQcCJcuLHeAIhMlt47JDNGtnZTZKIunAhdBQYaRjKt-G1cl4yowbobej52u1sIa_2_-FgBQl2aukiB2ul606rJTQPu_KMIEJJbQ6M0WHwVekrY-dHRtv1Akfd8iRNQ0Q0_XeI2jUimZLCnPkNxBcmyQBty9E-ffByXuklMOCVyG8hHz20zm-W0m8wLdo4lCDIcrX6KDZde7V0CAls3rYVH_AtgjB-A
  priority: 102
  providerName: Scholars Portal
Title Reduced Autophagy in 5-Fluorouracil Resistant Colon Cancer Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/27737524
https://www.proquest.com/docview/1835411692
https://pubmed.ncbi.nlm.nih.gov/PMC5424642
http://doi.org/10.4062/biomolther.2016.069
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002220510
UnpaywallVersion submittedVersion
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Biomolecules & Therapeutics, 2017, 25(3), , pp.315-320
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1976-9148
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067156
  issn: 1976-9148
  databaseCode: KQ8
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1976-9148
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067156
  issn: 1976-9148
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 1976-9148
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067156
  issn: 1976-9148
  databaseCode: 5-W
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1976-9148
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0067156
  issn: 1976-9148
  databaseCode: RPM
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1976-9148
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0067156
  issn: 1976-9148
  databaseCode: M48
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9tAEF414dBe-lBfbilyqx7r1N6ncyOKiGglUIVAoqfVeh8QxVojx1YFv55ZOwQiaEVPPnjWq53Z8XzjWX-D0Fdlc-KstglPCU3oGBdJbrhNaGasJso41xXaDw75_gn9ecpOb2ly7pTvIdLg7-Ef9KoMUCicwuKjlI8HaIszwN1DtHVy-GvyuysbCw5e27XK6qg1IecgPcXQ356yEYYGvnYPIcz7ByWftv5CXf5RZXknCs1e9O2Mlh15YTh8shi1TTHSV_epHR-xwJfo-QqMxpN-97xCT6x_jXaPApurNfGkDaQD6uwynvuYJbOyrWoYofS8jI_sMgBP38RTeHv6eBo2Tx1PbVku36Dj2d7xdD9Z9VlINMCRJlFYG2KUA2iUcs0LPSYa3NJZmilBUwtZimYEC2dswcGCIi8cRH5iioxppclbNPSVt-9RrDhz3DFqc0EoQDOVGmrB3oQzaiwREcI3Wpd6xUEeWmGUEnKRoA95qw8Z9CFBHxH6th500VNw_Fv8C5hTLvRcBurscD2r5KKWkCD8kBnhkIKC0Ocba0vwp1AkUd5W7VJm4UtYlvExjtC73vrrWbEQRDBMIyQ29sVaIEy4ecfPzzvObkYxhVQvQsl6Bz1mMR_-U_4jeoYD7uhOZG6jYVO39hOgpqbYQYMDmu-snOYaUUcX7Q
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbo9gAXHuIVKCggjnhJ_Ny9dbXqqiBRoaqVysly_GhXGzlVNhFqf33HyXbbVQsqpxwyjuUZT-abjPMNQl-0G1HvjMMiowyzMSnwyAqHWW6dodp63xXafx6I_WP244Sf3NDk3CrfQ6Qh3-I_6FUZoVA8hSWGmRhvoW3BAXcP0Pbxwa_J765sLAV4bdcqq6PWhJyD9hRDf3vKRhjaCrW_D2HePSj5uA3n-uKPLstbUWj2rG9ntOzIC-Phk8WwbYqhubxL7fiABT5HT1dgNJ30u-cFeuTCS7R7GNlcnU0nbSQd0KcX6TykHM_KtqphhDbzMj10ywg8Q5NO4e0Z0mncPHU6dWW5fIWOZntH03286rOADcCRBmtiLLXaAzTKhBGFGVMDbukdy7VkmYMsxXBKpLeuEGBBOSo8RH5qi5wbbehrNAhVcG9RqgX3wnPmRpIygGY6s8yBvangzDoqE0Suta7MioM8tsIoFeQiUR_qRh8q6kOBPhL0dT3ovKfg-Lf4ZzCnWpi5itTZ8XpaqUWtIEH4rnIqIAUFoU_X1lbgT7FIooOr2qXK45ewPBdjkqA3vfXXsxIpqeSEJUhu7Iu1QJxw806Yn3Wc3ZwRBqlegvB6Bz1kMe_-U_49ekIi7uhOZO6gQVO37gOgpqb4uHKXK8fPFxM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+Autophagy+in+5-Fluorouracil+Resistant+Colon+Cancer+Cells&rft.jtitle=Biomolecules+%26+therapeutics&rft.au=Cheng+Wen+Yao&rft.au=%EA%B0%95%EA%B2%BD%EC%95%84&rft.au=Mei+Jing+Piao&rft.au=%EB%A5%98%EC%98%88%EC%84%B1&rft.date=2017-05-01&rft.pub=%ED%95%9C%EA%B5%AD%EC%9D%91%EC%9A%A9%EC%95%BD%EB%AC%BC%ED%95%99%ED%9A%8C&rft.issn=1976-9148&rft.eissn=2005-4483&rft.spage=315&rft.epage=320&rft_id=info:doi/10.4062%2Fbiomolther.2016.069&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_1366019
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-4483&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-4483&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-4483&client=summon